Open AccessDRUG TREATMENT OF CYSTIC FIBROSIS PATIENTS IN RUSSIAN FEDERATION ACCORDING TO THE NATIONAL REGISTER, 2014
Author(s) -
С. А. Красовский,
E. Amelina,
E.I. Kondratyeva,
А. Ю. Воронкова,
А. В. Черняк,
Ю. В. Горинова,
M. Usacheva,
N. Revel-Muroz,
Н. И. Романенко,
M. Rybalkina,
T. Safonova,
N. Satsuk,
D.F. Sergienko Sergienko,
V. Seroklinov,
T. Simanova,
O. Simonova,
M. Skachkova,
В. В. Смирнова,
I. Smirnova,
О. И. Стародубцева,
T. Stashkevich,
Т. А. Степаненко,
V. Chikunov,
L. Shabalova,
O. Golubtsova,
V. Shadrina,
O. Zonenko,
А. А. Шевлякова,
В. Д. Шерман,
Н. А. Карчевская,
Ж. К. Науменко,
И. Н. Бутюгина,
О. Ю. Грачева,
Marina Kevorkova,
В. Б. Яковлева,
Н. Ю. Каширская
Publication year - 2016
Publication title -
pulʹmonologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 6
eISSN - 2541-9617
pISSN - 0869-0189
DOI - 10.18093/0869-0189-2016-26-5-539-555
Subject(s) - ursodeoxycholic acid , medicine , antibiotics , cystic fibrosis , drug , hypertonic saline , gastroenterology , tonicity , saline , pharmacology , chemistry , biochemistry
The aim of this study was to analyze drug therapy of patients with cystic fibrosis (CF) in Russia. Methods. Findings of the Russian National Register of CF patients, 2014, were used in this study. The 2014 Register included data for 2,131 patients (2,092 alive and 39 died) from 74 regions of Russia. The median age was 10.2 (15.2) years, 29.2% of patients were aged 18 years and older. We analyzed administration of bronchodilators, inhaled corticosteroids (ICS), systemic steroids, dornase alfa, hypertonic saline solution, macrolides, systemic and inhaled antibiotics, pancreatic enzymes, ursodeoxycholic acid, and fat-soluble vitamins. Results. Drug administration rates were as follows: bronchodilators, 65.9%; ICS, 21.7%; systemic steroids, 5.5%; macrolides, 32.4%; dornase-alfa, 92.8%; hypertonic saline solution, 45.9%; intravenous antibiotics, 62.3%; oral antibiotics, 73.3%; inhaled antibiotics, 41.3%; pancreatic enzymes, 93.3%; ursodeoxycholic acid, 91.4%; and fat-soluble vitamins, 88.3%. Conclusion . Compared to treatment of CF patients in the Western Europe, there is higher rate of administration of pancreatic enzymes, ursodeoxycholic acid, dornase alfa, hypertonic saline solution and intravenous antibiotics in Russia. Compared to treatment strategy in USA, there is higher rate of administration of pancreatic enzymes and lower rate of administration of bronchodilators, hypertonic saline solution and inhaled antibiotics in Russia.